| 000 | 01516 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516051332.0 | ||
| 264 | 0 | _c20121211 | |
| 008 | 201212s 0 0 fre d | ||
| 022 | _a0040-5957 | ||
| 024 | 7 |
_a10.2515/therapie/2011028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChaabane, Amel | |
| 245 | 0 | 0 |
_a[H1N1 influenza vaccines in Tunisia: efficiency and safety]. _h[electronic resource] |
| 260 |
_bTherapie _c |
||
| 300 |
_a281-9 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Programs |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aInfluenza, Human _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTunisia |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAouam, Karim | |
| 700 | 1 | _aBen Fredj, Nadia | |
| 700 | 1 | _aToumi, Adnen | |
| 700 | 1 | _aBraham, Dorra | |
| 700 | 1 | _aA Boughattas, Naceur | |
| 700 | 1 | _aChakroun, Mohamed | |
| 773 | 0 |
_tTherapie _gvol. 66 _gno. 3 _gp. 281-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2515/therapie/2011028 _zAvailable from publisher's website |
| 999 |
_c21064768 _d21064768 |
||